3P Biopharmaceuticals, a contract development and manufacturing organization (CDMO) specialized in the process development and GMP production of biologics, has completed the project for the expansion and improvement of its facilities in Noáin, Spain that had been carried out over the past few months. The investment exceeded the €5 million in addition to the €8 million that 3P has invested since 2013.   The new facility design is part of the company’s strategic plan designed to position 3P as a...